Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
Cholesterol-Lowering Drugs May Prevent Breast Cancer
Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
NCCN Updates Breast Cancer Guidelines for Patients
Lung Cancer Clinical Trials Cost-Effective Alternative
Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
New Drug Reduces Nausea and Vomiting
Clinical Trials Approved By NCI
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Foundations acquire a critical new role as federal funding for cancer research falters
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- Our challenge: To find zen in chaos
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”